Dr. Bakouny on the Rate of Disease Progression in Sarcomatoid Carcinoma

Ziad Bakouny, MD, MSc, postdoctoral genitourinary oncology research fellow, Dana-Farber Cancer Institute, discusses the rate of disease progression in sarcomatoid carcinoma.

Despite recent advances in the sarcomatoid carcinoma armamentarium with therapies​, such as ​the introduction of checkpoint inhibitors, patients with sarcomatoid carcinoma tend to progress very rapidly, says Bakouny.

As such, it ​is important to note that ​patients' tumors may develop ​into a more severe and symptomatic disease presentation if patientsdo not respond to therapy, ​Bakouny explains.

In the clinical setting, nurses tend to be sensitive to the risk of disease progression among patients with sarcomatoid carcinoma, Bakouny concludes.